SCHEDULE: SCYNEXIS Inc. Ownership Update

Federated Hermes, Inc. and related entities report a 4.03% beneficial ownership stake in SCYNEXIS Inc. as of June 30, 2026.

Summary

• Federated Hermes, Inc., along with the Voting Shares Irrevocable Trust, Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue, have collectively reported beneficial ownership of 441,658 shares of SCYNEXIS Inc. common stock.
• This holding represents 4.03% of the class of securities.
• The filing is an amendment to a Schedule 13G, indicating a change in ownership reporting.
• The reporting persons have disclaimed beneficial ownership beyond their direct holdings, stating the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard ownership disclosure and does not contain performance data or strategic announcements that would typically influence sentiment.

Positives

• Federated Hermes, Inc. and associated entities maintain a significant ownership stake, indicating continued investment interest.
• The reporting persons hold sole voting and dispositive power over the reported shares, suggesting clear control over their investment decisions.

Negatives

• The filing explicitly disclaims beneficial ownership of securities held by managed funds, which could indicate a complex ownership structure or a desire to limit liability.
• The disclaimer regarding not holding shares for the purpose of influencing control might be interpreted as a cautious stance or a response to potential regulatory scrutiny.

Risks

• The disclaimer of beneficial ownership for managed funds could lead to uncertainty regarding the ultimate control and influence over SCYNEXIS Inc.
• The explicit statement that shares are not held for influencing control might suggest a perception of potential challenges to corporate governance or a need to preemptively address such concerns.

Future Outlook

No specific future outlook or guidance is provided in this Schedule 13G filing, as it pertains to ownership reporting rather than company performance.

Management Comments

• In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine for institutional investors crossing certain ownership thresholds. This filing indicates a significant, but not controlling, stake by Federated Hermes and related entities in SCYNEXIS Inc., a biotechnology company.

Stakeholder Impact

• Shareholders: The filing provides transparency on a significant institutional investor's stake, which can influence market perception.
• Management: The disclaimer regarding control may signal a need for clear communication with significant shareholders.
• Creditors: No direct impact is indicated.

Next Steps

• Continued monitoring of SCYNEXIS Inc. by Federated Hermes, Inc. and associated entities.
• Potential future amendments to Schedule 13G if ownership levels change significantly.

Key Dates

Keywords

SCYNEXIS Inc., Schedule 13G, Federated Hermes, Beneficial Ownership, Common Stock, Ownership Stake, Investment, SEC Filing